TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for CRYGD
check button Gene summary
Basic gene informationGene symbolCRYGD
Gene namecrystallin, gamma D
SynonymsCACA|CCA3|CCP|CRYG4|CTRCT4|PCC|cry-g-D
CytomapUCSC genome browser: 2q33.3
Type of geneprotein-coding
RefGenesNM_006891.3,
Descriptiongamma crystallin 4gamma-D-crystallingamma-crystallin 4gamma-crystallin D
Modification date20141207
dbXrefs MIM : 123690
HGNC : HGNC
Ensembl : ENSG00000118231
HPRD : 00436
Vega : OTTHUMG00000132944
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_CRYGD
BioGPS: 1421
PathwayNCI Pathway Interaction Database: CRYGD
KEGG: CRYGD
REACTOME: CRYGD
Pathway Commons: CRYGD
ContextiHOP: CRYGD
ligand binding site mutation search in PubMed: CRYGD
UCL Cancer Institute: CRYGD
Assigned class in TissGDB*A
Included tissue-specific gene expression resourcesHPA,TiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)OvaryEye
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)OVUVM
Reference showing the relevant tissue of CRYGDAntagonistic action of Six3 and Prox1 at the gamma-crystallin promoter. Lengler J, Krausz E, Tomarev S, Prescott A, Quinlan RA, Graw J. Nucleic Acids Res. 2001 Jan 15;29(2):515-26. (pmid:11139622)
go to article
Description by TissGene annotationsCancer gene
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID
GO:0034614cellular response to reactive oxygen species8943244
GO:0034614cellular response to reactive oxygen species8943244


Top
TissGeneExp for CRYGD

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR


Top
TissGene-miRNA for CRYGD

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for CRYGD
TissGeneSNV for CRYGD

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.A36VKIRP2
p.A36VPAAD2
p.D74NSTAD1
p.R152MSARC1
p.R115HPAAD1
p.Q77KLUSC1
p.S40RLUSC1
p.D108YLUAD1
p.H122YSKCM1
p.A36VLIHC1
p.W131*BLCA1
p.R140QHNSC1
p.S137PHNSC1
p.G149ESKCM1
p.G41RPAAD1
p.S78YLUAD1
p.N125KLUSC1
p.Y134*LIHC1
p.R117GESCA1
p.R117HUCEC1
p.E120GPRAD1
p.I171MLUAD1
p.S174TLUAD1
p.L6PSKCM1
p.R142QLUSC1
p.D150EGBM1
p.S52WMESO1
p.Y134XLIHC1
p.E128KSKCM1
p.D65NSTAD1


Top
TissGeneCNV for CRYGD

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for CRYGD

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for CRYGD

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)


Top
TissGeneProg for CRYGD

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for CRYGD
TissGeneDrug for CRYGD

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for CRYGD

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0003873Rheumatoid Arthritis81BeFree
umls:C0086543Cataract26BeFree,CTD_human,LHGDN
umls:C0009691Congenital cataract8BeFree
umls:C0003864Arthritis6BeFree
umls:C0031511Pheochromocytoma6BeFree
umls:C3540850CATARACT 4, MULTIPLE TYPES6CTD_human,MGD,UNIPROT
umls:C0521707Bilateral cataracts (disorder)5BeFree
umls:C0025268Multiple Endocrine Neoplasia Type 2a4BeFree
umls:C0030421Paraganglioma4BeFree
umls:C0242379Malignant neoplasm of lung3BeFree
umls:C0268579Propionic acidemia3BeFree
umls:C0684249Carcinoma of lung3BeFree
umls:C1861832CATARACT, CRYSTALLINE ACULEIFORM3BeFree
umls:C0003872Arthritis, Psoriatic2BeFree
umls:C0007222Cardiovascular Diseases2BeFree
umls:C0008626Congenital chromosomal disease2BeFree
umls:C0027627Neoplasm Metastasis2BeFree
umls:C0162323Polyarthritis2BeFree
umls:C0302254Juvenile cataract2BeFree
umls:C0333307Superficial ulcer2BeFree
umls:C0376358Malignant neoplasm of prostate2BeFree
umls:C0600139Prostate carcinoma2BeFree
umls:C1692871Inflammatory polyarthritis2BeFree
umls:C3714757Juvenile rheumatoid arthritis2BeFree
umls:C0002395Alzheimer's Disease1BeFree
umls:C0003850Arteriosclerosis1BeFree
umls:C0004135Ataxia Telangiectasia1BeFree
umls:C0004153Atherosclerosis1BeFree
umls:C0009402Colorectal Carcinoma1BeFree
umls:C0010403Cryoglobulinemia1BeFree
umls:C0011854Diabetes Mellitus, Insulin-Dependent1BeFree
umls:C0017563Gingival Diseases1BeFree
umls:C0019562Von Hippel-Lindau Syndrome1BeFree
umls:C0022408Arthropathy1BeFree
umls:C0025521Inborn Errors of Metabolism1BeFree
umls:C0027697Nephritis1BeFree
umls:C0031090Periodontal Diseases1BeFree
umls:C0031099Periodontitis1BeFree
umls:C0035435Rheumatism1BeFree
umls:C0036646Age-related cataract1BeFree
umls:C0038454Cerebrovascular accident1BeFree
umls:C0039103Synovitis1BeFree
umls:C0085574Palindromic rheumatism1BeFree
umls:C0086692Benign Neoplasm1BeFree
umls:C0152013Adenocarcinoma of lung (disorder)1BeFree
umls:C0152031Joint swelling1BeFree
umls:C0238462Medullary carcinoma of thyroid1BeFree
umls:C0260037Multiple tumors1BeFree
umls:C0278701Gastric Adenocarcinoma1BeFree
umls:C0280100Solid tumour1BeFree
umls:C0392514Hereditary hemochromatosis1BeFree
umls:C0409679Seronegative arthritis1BeFree
umls:C0494165Secondary malignant neoplasm of liver1BeFree
umls:C0543697Mixed cryoglobulinemia1BeFree
umls:C0949690Spondylarthritis1BeFree
umls:C1510497Lens Opacities1BeFree
umls:C1527249Colorectal Cancer1BeFree
umls:C1832526CATARACT, NONNUCLEAR POLYMORPHIC CONGENITAL, AUTOSOMAL DOMINANT1BeFree
umls:C1858592Carney Triad1BeFree
umls:C3495559Juvenile arthritis1BeFree
umls:C0344523Cataract, congenital, cerulean type 10ORPHANET
umls:C0392557Nuclear cataract0ORPHANET
umls:C1112705Nuclear non-senile cataract0ORPHANET
umls:C1852438CATARACT, COPPOCK-LIKE0MGD
umls:C1861829Cataract microcornea syndrome0ORPHANET
umls:C3805409CATARACT 290ORPHANET